Latest Cancer News

Calquence Improves Survival in Relapsed Chronic Lymphocytic Leukemia (05-20-2019)
An interim analyses of the phase 3 “ASCEND” clinical trial evaluating single-agent Calquence (acalabrutinib) compared to Rituxan (rituximab) plus idelasib or bendamustine in recurrent chronic lymphocytic... Continue Reading

Zytig Treatment Prolongs Survival in Advanced Prostate Cancer (05-7-2019)
Zytig (Abiraterone acetate) plus prednisone and androgen deprivation therapy (ADT) significantly extends overall survival compared with placebo plus ADT in men with newly diagnosed high-risk metastatic... Continue Reading

FDA approves ivosidenib as first-line treatment for AML with IDH1 mutation (05-7-2019)
On May 2, 2019, the Food and Drug Administration approved ivosidenib (TIBSOVO, Agios Pharmaceuticals, Inc.) for newly-diagnosed acute myeloid leukemia (AML) with a susceptible IDH1 mutation, as detected... Continue Reading

More Cancer News

Locations

 

Lake Worth, FL
3450 Lantana Rd. Suite 100
Lake Worth, FL 33462
561.965-1864

Boynton Beach, FL
2300 S. Congress Ave Suite 103
Boynton Beach, FL 33426
561.732-2440

 

Loxahatchee, FL
12993 Southern Blvd., Suite B
Loxahatchee, FL 33470
561.793-0106